nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2B—Sorafenib—kidney cancer	0.0995	0.606	CbGbCtD
Apomorphine—HTR2C—Sorafenib—kidney cancer	0.0647	0.394	CbGbCtD
Apomorphine—Loss of consciousness—Everolimus—kidney cancer	0.00275	0.00365	CcSEcCtD
Apomorphine—Mental disorder—Sorafenib—kidney cancer	0.00273	0.00363	CcSEcCtD
Apomorphine—Swelling—Capecitabine—kidney cancer	0.00271	0.0036	CcSEcCtD
Apomorphine—Dehydration—Paclitaxel—kidney cancer	0.00271	0.0036	CcSEcCtD
Apomorphine—Syncope—Erlotinib—kidney cancer	0.0027	0.00359	CcSEcCtD
Apomorphine—Pneumonia—Gemcitabine—kidney cancer	0.00269	0.00358	CcSEcCtD
Apomorphine—Arthralgia—Everolimus—kidney cancer	0.00266	0.00353	CcSEcCtD
Apomorphine—Chest pain—Everolimus—kidney cancer	0.00266	0.00353	CcSEcCtD
Apomorphine—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00266	0.00353	CcSEcCtD
Apomorphine—Anxiety—Everolimus—kidney cancer	0.00265	0.00352	CcSEcCtD
Apomorphine—Loss of consciousness—Erlotinib—kidney cancer	0.00265	0.00352	CcSEcCtD
Apomorphine—Flushing—Dactinomycin—kidney cancer	0.00263	0.0035	CcSEcCtD
Apomorphine—Mental disorder—Sunitinib—kidney cancer	0.00263	0.00349	CcSEcCtD
Apomorphine—Nasopharyngitis—Paclitaxel—kidney cancer	0.0026	0.00346	CcSEcCtD
Apomorphine—Arthralgia—Erlotinib—kidney cancer	0.00257	0.00341	CcSEcCtD
Apomorphine—Chest pain—Erlotinib—kidney cancer	0.00257	0.00341	CcSEcCtD
Apomorphine—Anxiety—Erlotinib—kidney cancer	0.00256	0.0034	CcSEcCtD
Apomorphine—Oedema—Everolimus—kidney cancer	0.00255	0.00339	CcSEcCtD
Apomorphine—Back pain—Sunitinib—kidney cancer	0.00252	0.00335	CcSEcCtD
Apomorphine—Hallucination—Vincristine—kidney cancer	0.00252	0.00335	CcSEcCtD
Apomorphine—Shock—Everolimus—kidney cancer	0.00251	0.00333	CcSEcCtD
Apomorphine—Hyperhidrosis—Everolimus—kidney cancer	0.00246	0.00328	CcSEcCtD
Apomorphine—Oedema—Erlotinib—kidney cancer	0.00246	0.00327	CcSEcCtD
Apomorphine—Asthenia—Temsirolimus—kidney cancer	0.00246	0.00327	CcSEcCtD
Apomorphine—Sweating increased—Paclitaxel—kidney cancer	0.00245	0.00326	CcSEcCtD
Apomorphine—Syncope—Sorafenib—kidney cancer	0.00243	0.00323	CcSEcCtD
Apomorphine—Pruritus—Temsirolimus—kidney cancer	0.00242	0.00322	CcSEcCtD
Apomorphine—Shock—Erlotinib—kidney cancer	0.00242	0.00322	CcSEcCtD
Apomorphine—Pain in extremity—Capecitabine—kidney cancer	0.00239	0.00317	CcSEcCtD
Apomorphine—Loss of consciousness—Sorafenib—kidney cancer	0.00238	0.00317	CcSEcCtD
Apomorphine—Hypotension—Everolimus—kidney cancer	0.00238	0.00317	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.00237	0.00315	CcSEcCtD
Apomorphine—Diarrhoea—Temsirolimus—kidney cancer	0.00234	0.00312	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00232	0.00309	CcSEcCtD
Apomorphine—Asthenia—Pazopanib—kidney cancer	0.00232	0.00308	CcSEcCtD
Apomorphine—Arthralgia—Sorafenib—kidney cancer	0.00231	0.00307	CcSEcCtD
Apomorphine—Insomnia—Everolimus—kidney cancer	0.00231	0.00306	CcSEcCtD
Apomorphine—Pruritus—Pazopanib—kidney cancer	0.00228	0.00304	CcSEcCtD
Apomorphine—Dyspnoea—Everolimus—kidney cancer	0.00227	0.00302	CcSEcCtD
Apomorphine—Somnolence—Everolimus—kidney cancer	0.00227	0.00301	CcSEcCtD
Apomorphine—Dizziness—Temsirolimus—kidney cancer	0.00227	0.00301	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—kidney cancer	0.00226	0.003	CcSEcCtD
Apomorphine—Pneumonia—Paclitaxel—kidney cancer	0.00226	0.003	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00224	0.00298	CcSEcCtD
Apomorphine—Insomnia—Erlotinib—kidney cancer	0.00222	0.00296	CcSEcCtD
Apomorphine—Chest pain—Sunitinib—kidney cancer	0.00222	0.00295	CcSEcCtD
Apomorphine—Arthralgia—Sunitinib—kidney cancer	0.00222	0.00295	CcSEcCtD
Apomorphine—Dehydration—Capecitabine—kidney cancer	0.00222	0.00295	CcSEcCtD
Apomorphine—Mental disorder—Vincristine—kidney cancer	0.00222	0.00295	CcSEcCtD
Apomorphine—Diarrhoea—Pazopanib—kidney cancer	0.00221	0.00294	CcSEcCtD
Apomorphine—Fatigue—Everolimus—kidney cancer	0.0022	0.00292	CcSEcCtD
Apomorphine—Dyspnoea—Erlotinib—kidney cancer	0.00219	0.00291	CcSEcCtD
Apomorphine—Constipation—Vinblastine—kidney cancer	0.00219	0.00291	CcSEcCtD
Apomorphine—Orthostatic hypotension—Capecitabine—kidney cancer	0.00218	0.0029	CcSEcCtD
Apomorphine—Urinary tract infection—Paclitaxel—kidney cancer	0.00218	0.0029	CcSEcCtD
Apomorphine—Constipation—Everolimus—kidney cancer	0.00218	0.0029	CcSEcCtD
Apomorphine—Vomiting—Temsirolimus—kidney cancer	0.00218	0.0029	CcSEcCtD
Apomorphine—Shock—Sorafenib—kidney cancer	0.00218	0.00289	CcSEcCtD
Apomorphine—Headache—Temsirolimus—kidney cancer	0.00215	0.00285	CcSEcCtD
Apomorphine—Nasopharyngitis—Capecitabine—kidney cancer	0.00214	0.00284	CcSEcCtD
Apomorphine—Dizziness—Pazopanib—kidney cancer	0.00214	0.00284	CcSEcCtD
Apomorphine—Back pain—Vincristine—kidney cancer	0.00213	0.00284	CcSEcCtD
Apomorphine—Oedema—Sunitinib—kidney cancer	0.00213	0.00283	CcSEcCtD
Apomorphine—Fatigue—Erlotinib—kidney cancer	0.00212	0.00282	CcSEcCtD
Apomorphine—Feeling abnormal—Vinblastine—kidney cancer	0.00211	0.0028	CcSEcCtD
Apomorphine—Injection site reaction—Doxorubicin—kidney cancer	0.00211	0.0028	CcSEcCtD
Apomorphine—Constipation—Erlotinib—kidney cancer	0.0021	0.0028	CcSEcCtD
Apomorphine—Feeling abnormal—Everolimus—kidney cancer	0.0021	0.00279	CcSEcCtD
Apomorphine—Shock—Sunitinib—kidney cancer	0.00209	0.00278	CcSEcCtD
Apomorphine—Vomiting—Pazopanib—kidney cancer	0.00205	0.00273	CcSEcCtD
Apomorphine—Nausea—Temsirolimus—kidney cancer	0.00204	0.00271	CcSEcCtD
Apomorphine—Back pain—Gemcitabine—kidney cancer	0.00202	0.00269	CcSEcCtD
Apomorphine—Headache—Pazopanib—kidney cancer	0.00202	0.00269	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00202	0.00268	CcSEcCtD
Apomorphine—Oedema—Dactinomycin—kidney cancer	0.00202	0.00268	CcSEcCtD
Apomorphine—Sweating increased—Capecitabine—kidney cancer	0.00201	0.00267	CcSEcCtD
Apomorphine—Angina pectoris—Capecitabine—kidney cancer	0.00201	0.00267	CcSEcCtD
Apomorphine—Dyspnoea—Sorafenib—kidney cancer	0.00197	0.00262	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00194	0.00258	CcSEcCtD
Apomorphine—Insomnia—Sunitinib—kidney cancer	0.00193	0.00256	CcSEcCtD
Apomorphine—Nausea—Pazopanib—kidney cancer	0.00192	0.00255	CcSEcCtD
Apomorphine—Ecchymosis—Doxorubicin—kidney cancer	0.00192	0.00255	CcSEcCtD
Apomorphine—Fatigue—Sorafenib—kidney cancer	0.00191	0.00254	CcSEcCtD
Apomorphine—Dyspnoea—Sunitinib—kidney cancer	0.0019	0.00252	CcSEcCtD
Apomorphine—Constipation—Sorafenib—kidney cancer	0.00189	0.00251	CcSEcCtD
Apomorphine—Flushing—Paclitaxel—kidney cancer	0.00187	0.00248	CcSEcCtD
Apomorphine—Pneumonia—Capecitabine—kidney cancer	0.00185	0.00246	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00184	0.00244	CcSEcCtD
Apomorphine—Asthenia—Vinblastine—kidney cancer	0.00184	0.00244	CcSEcCtD
Apomorphine—Fatigue—Sunitinib—kidney cancer	0.00184	0.00244	CcSEcCtD
Apomorphine—Asthenia—Everolimus—kidney cancer	0.00183	0.00243	CcSEcCtD
Apomorphine—Constipation—Sunitinib—kidney cancer	0.00182	0.00242	CcSEcCtD
Apomorphine—Pruritus—Everolimus—kidney cancer	0.0018	0.0024	CcSEcCtD
Apomorphine—Oedema—Vincristine—kidney cancer	0.0018	0.00239	CcSEcCtD
Apomorphine—Urinary tract infection—Capecitabine—kidney cancer	0.00179	0.00238	CcSEcCtD
Apomorphine—Chest pain—Gemcitabine—kidney cancer	0.00178	0.00237	CcSEcCtD
Apomorphine—Arthralgia—Gemcitabine—kidney cancer	0.00178	0.00237	CcSEcCtD
Apomorphine—Asthenia—Erlotinib—kidney cancer	0.00176	0.00235	CcSEcCtD
Apomorphine—Mental disorder—Paclitaxel—kidney cancer	0.00176	0.00234	CcSEcCtD
Apomorphine—Diarrhoea—Vinblastine—kidney cancer	0.00175	0.00233	CcSEcCtD
Apomorphine—Diarrhoea—Everolimus—kidney cancer	0.00174	0.00232	CcSEcCtD
Apomorphine—Hyperhidrosis—Vincristine—kidney cancer	0.00174	0.00231	CcSEcCtD
Apomorphine—Pruritus—Erlotinib—kidney cancer	0.00174	0.00231	CcSEcCtD
Apomorphine—Fatigue—Dactinomycin—kidney cancer	0.00174	0.00231	CcSEcCtD
Apomorphine—Oedema—Gemcitabine—kidney cancer	0.00171	0.00227	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.0017	0.00226	CcSEcCtD
Apomorphine—Back pain—Paclitaxel—kidney cancer	0.0017	0.00225	CcSEcCtD
Apomorphine—Dizziness—Vinblastine—kidney cancer	0.00169	0.00225	CcSEcCtD
Apomorphine—Dizziness—Everolimus—kidney cancer	0.00169	0.00224	CcSEcCtD
Apomorphine—Diarrhoea—Erlotinib—kidney cancer	0.00168	0.00224	CcSEcCtD
Apomorphine—Hypotension—Vincristine—kidney cancer	0.00168	0.00224	CcSEcCtD
Apomorphine—Feeling abnormal—Dactinomycin—kidney cancer	0.00166	0.00221	CcSEcCtD
Apomorphine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00165	0.0022	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00164	0.00218	CcSEcCtD
Apomorphine—Insomnia—Vincristine—kidney cancer	0.00163	0.00216	CcSEcCtD
Apomorphine—Vomiting—Vinblastine—kidney cancer	0.00163	0.00216	CcSEcCtD
Apomorphine—Dizziness—Erlotinib—kidney cancer	0.00163	0.00216	CcSEcCtD
Apomorphine—Vomiting—Everolimus—kidney cancer	0.00162	0.00215	CcSEcCtD
Apomorphine—Headache—Vinblastine—kidney cancer	0.0016	0.00213	CcSEcCtD
Apomorphine—Headache—Everolimus—kidney cancer	0.0016	0.00212	CcSEcCtD
Apomorphine—Hypotension—Gemcitabine—kidney cancer	0.0016	0.00212	CcSEcCtD
Apomorphine—Asthenia—Sorafenib—kidney cancer	0.00159	0.00211	CcSEcCtD
Apomorphine—Syncope—Paclitaxel—kidney cancer	0.00157	0.00209	CcSEcCtD
Apomorphine—Pruritus—Sorafenib—kidney cancer	0.00157	0.00208	CcSEcCtD
Apomorphine—Vomiting—Erlotinib—kidney cancer	0.00156	0.00208	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00156	0.00207	CcSEcCtD
Apomorphine—Fatigue—Vincristine—kidney cancer	0.00155	0.00206	CcSEcCtD
Apomorphine—Insomnia—Gemcitabine—kidney cancer	0.00155	0.00205	CcSEcCtD
Apomorphine—Headache—Erlotinib—kidney cancer	0.00154	0.00205	CcSEcCtD
Apomorphine—Loss of consciousness—Paclitaxel—kidney cancer	0.00154	0.00205	CcSEcCtD
Apomorphine—Constipation—Vincristine—kidney cancer	0.00154	0.00205	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—kidney cancer	0.00154	0.00205	CcSEcCtD
Apomorphine—Flushing—Capecitabine—kidney cancer	0.00153	0.00204	CcSEcCtD
Apomorphine—Asthenia—Sunitinib—kidney cancer	0.00153	0.00203	CcSEcCtD
Apomorphine—Dyspnoea—Gemcitabine—kidney cancer	0.00152	0.00202	CcSEcCtD
Apomorphine—Nausea—Vinblastine—kidney cancer	0.00152	0.00202	CcSEcCtD
Apomorphine—Somnolence—Gemcitabine—kidney cancer	0.00152	0.00202	CcSEcCtD
Apomorphine—Nausea—Everolimus—kidney cancer	0.00151	0.00201	CcSEcCtD
Apomorphine—Diarrhoea—Sorafenib—kidney cancer	0.00151	0.00201	CcSEcCtD
Apomorphine—Pruritus—Sunitinib—kidney cancer	0.00151	0.002	CcSEcCtD
Apomorphine—Arthralgia—Paclitaxel—kidney cancer	0.00149	0.00198	CcSEcCtD
Apomorphine—Chest pain—Paclitaxel—kidney cancer	0.00149	0.00198	CcSEcCtD
Apomorphine—Anxiety—Paclitaxel—kidney cancer	0.00149	0.00198	CcSEcCtD
Apomorphine—Fatigue—Gemcitabine—kidney cancer	0.00147	0.00196	CcSEcCtD
Apomorphine—Dizziness—Sorafenib—kidney cancer	0.00146	0.00194	CcSEcCtD
Apomorphine—Constipation—Gemcitabine—kidney cancer	0.00146	0.00194	CcSEcCtD
Apomorphine—Nausea—Erlotinib—kidney cancer	0.00146	0.00194	CcSEcCtD
Apomorphine—Diarrhoea—Sunitinib—kidney cancer	0.00146	0.00194	CcSEcCtD
Apomorphine—Mental disorder—Capecitabine—kidney cancer	0.00145	0.00192	CcSEcCtD
Apomorphine—Asthenia—Dactinomycin—kidney cancer	0.00145	0.00192	CcSEcCtD
Apomorphine—Confusional state—Paclitaxel—kidney cancer	0.00144	0.00192	CcSEcCtD
Apomorphine—Dehydration—Doxorubicin—kidney cancer	0.00143	0.0019	CcSEcCtD
Apomorphine—Oedema—Paclitaxel—kidney cancer	0.00143	0.0019	CcSEcCtD
Apomorphine—Dizziness—Sunitinib—kidney cancer	0.00141	0.00187	CcSEcCtD
Apomorphine—Feeling abnormal—Gemcitabine—kidney cancer	0.00141	0.00187	CcSEcCtD
Apomorphine—Shock—Paclitaxel—kidney cancer	0.00141	0.00187	CcSEcCtD
Apomorphine—Vomiting—Sorafenib—kidney cancer	0.00141	0.00187	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00141	0.00187	CcSEcCtD
Apomorphine—Back pain—Capecitabine—kidney cancer	0.00139	0.00185	CcSEcCtD
Apomorphine—Headache—Sorafenib—kidney cancer	0.00139	0.00184	CcSEcCtD
Apomorphine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00138	0.00184	CcSEcCtD
Apomorphine—Diarrhoea—Dactinomycin—kidney cancer	0.00138	0.00183	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—kidney cancer	0.00138	0.00183	CcSEcCtD
Apomorphine—Vomiting—Sunitinib—kidney cancer	0.00135	0.0018	CcSEcCtD
Apomorphine—Hypotension—Paclitaxel—kidney cancer	0.00134	0.00178	CcSEcCtD
Apomorphine—Headache—Sunitinib—kidney cancer	0.00133	0.00177	CcSEcCtD
Apomorphine—Nausea—Sorafenib—kidney cancer	0.00131	0.00175	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.0013	0.00173	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—kidney cancer	0.0013	0.00172	CcSEcCtD
Apomorphine—Insomnia—Paclitaxel—kidney cancer	0.00129	0.00172	CcSEcCtD
Apomorphine—Asthenia—Vincristine—kidney cancer	0.00129	0.00172	CcSEcCtD
Apomorphine—Syncope—Capecitabine—kidney cancer	0.00129	0.00171	CcSEcCtD
Apomorphine—Vomiting—Dactinomycin—kidney cancer	0.00128	0.0017	CcSEcCtD
Apomorphine—Dyspnoea—Paclitaxel—kidney cancer	0.00128	0.00169	CcSEcCtD
Apomorphine—Somnolence—Paclitaxel—kidney cancer	0.00127	0.00169	CcSEcCtD
Apomorphine—Nausea—Sunitinib—kidney cancer	0.00126	0.00168	CcSEcCtD
Apomorphine—Loss of consciousness—Capecitabine—kidney cancer	0.00126	0.00168	CcSEcCtD
Apomorphine—Fatigue—Paclitaxel—kidney cancer	0.00123	0.00164	CcSEcCtD
Apomorphine—Diarrhoea—Vincristine—kidney cancer	0.00123	0.00164	CcSEcCtD
Apomorphine—Asthenia—Gemcitabine—kidney cancer	0.00123	0.00163	CcSEcCtD
Apomorphine—Chest pain—Capecitabine—kidney cancer	0.00122	0.00163	CcSEcCtD
Apomorphine—Arthralgia—Capecitabine—kidney cancer	0.00122	0.00163	CcSEcCtD
Apomorphine—Constipation—Paclitaxel—kidney cancer	0.00122	0.00163	CcSEcCtD
Apomorphine—Anxiety—Capecitabine—kidney cancer	0.00122	0.00162	CcSEcCtD
Apomorphine—Pruritus—Gemcitabine—kidney cancer	0.00121	0.00161	CcSEcCtD
Apomorphine—Nausea—Dactinomycin—kidney cancer	0.0012	0.00159	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—kidney cancer	0.00119	0.00159	CcSEcCtD
Apomorphine—Dizziness—Vincristine—kidney cancer	0.00119	0.00158	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—kidney cancer	0.00119	0.00158	CcSEcCtD
Apomorphine—Confusional state—Capecitabine—kidney cancer	0.00118	0.00157	CcSEcCtD
Apomorphine—Feeling abnormal—Paclitaxel—kidney cancer	0.00118	0.00157	CcSEcCtD
Apomorphine—Oedema—Capecitabine—kidney cancer	0.00117	0.00156	CcSEcCtD
Apomorphine—Diarrhoea—Gemcitabine—kidney cancer	0.00117	0.00155	CcSEcCtD
Apomorphine—Shock—Capecitabine—kidney cancer	0.00115	0.00153	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—kidney cancer	0.00115	0.00153	CcSEcCtD
Apomorphine—Vomiting—Vincristine—kidney cancer	0.00115	0.00152	CcSEcCtD
Apomorphine—Hyperhidrosis—Capecitabine—kidney cancer	0.00113	0.00151	CcSEcCtD
Apomorphine—Headache—Vincristine—kidney cancer	0.00113	0.0015	CcSEcCtD
Apomorphine—Hypotension—Capecitabine—kidney cancer	0.0011	0.00146	CcSEcCtD
Apomorphine—Vomiting—Gemcitabine—kidney cancer	0.00109	0.00144	CcSEcCtD
Apomorphine—Headache—Gemcitabine—kidney cancer	0.00107	0.00142	CcSEcCtD
Apomorphine—Nausea—Vincristine—kidney cancer	0.00107	0.00142	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00107	0.00142	CcSEcCtD
Apomorphine—Insomnia—Capecitabine—kidney cancer	0.00106	0.00141	CcSEcCtD
Apomorphine—Dyspnoea—Capecitabine—kidney cancer	0.00105	0.00139	CcSEcCtD
Apomorphine—Asthenia—Paclitaxel—kidney cancer	0.00103	0.00136	CcSEcCtD
Apomorphine—Nausea—Gemcitabine—kidney cancer	0.00101	0.00135	CcSEcCtD
Apomorphine—Fatigue—Capecitabine—kidney cancer	0.00101	0.00135	CcSEcCtD
Apomorphine—Pruritus—Paclitaxel—kidney cancer	0.00101	0.00135	CcSEcCtD
Apomorphine—Constipation—Capecitabine—kidney cancer	0.001	0.00133	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—kidney cancer	0.000988	0.00131	CcSEcCtD
Apomorphine—Diarrhoea—Paclitaxel—kidney cancer	0.000979	0.0013	CcSEcCtD
Apomorphine—Feeling abnormal—Capecitabine—kidney cancer	0.000967	0.00129	CcSEcCtD
Apomorphine—Dizziness—Paclitaxel—kidney cancer	0.000946	0.00126	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—kidney cancer	0.000933	0.00124	CcSEcCtD
Apomorphine—Vomiting—Paclitaxel—kidney cancer	0.00091	0.00121	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—kidney cancer	0.000897	0.00119	CcSEcCtD
Apomorphine—Headache—Paclitaxel—kidney cancer	0.000896	0.00119	CcSEcCtD
Apomorphine—Nausea—Paclitaxel—kidney cancer	0.00085	0.00113	CcSEcCtD
Apomorphine—Asthenia—Capecitabine—kidney cancer	0.000842	0.00112	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—kidney cancer	0.000831	0.00111	CcSEcCtD
Apomorphine—Pruritus—Capecitabine—kidney cancer	0.000831	0.0011	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—kidney cancer	0.000815	0.00108	CcSEcCtD
Apomorphine—Diarrhoea—Capecitabine—kidney cancer	0.000803	0.00107	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—kidney cancer	0.000789	0.00105	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—kidney cancer	0.000789	0.00105	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—kidney cancer	0.000787	0.00105	CcSEcCtD
Apomorphine—Dizziness—Capecitabine—kidney cancer	0.000776	0.00103	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—kidney cancer	0.000763	0.00101	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—kidney cancer	0.000757	0.00101	CcSEcCtD
Apomorphine—Vomiting—Capecitabine—kidney cancer	0.000746	0.000992	CcSEcCtD
Apomorphine—Shock—Doxorubicin—kidney cancer	0.000744	0.000989	CcSEcCtD
Apomorphine—Headache—Capecitabine—kidney cancer	0.000735	0.000977	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000732	0.000972	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—kidney cancer	0.000707	0.00094	CcSEcCtD
Apomorphine—Nausea—Capecitabine—kidney cancer	0.000697	0.000927	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000689	0.000916	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—kidney cancer	0.000684	0.00091	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—kidney cancer	0.000675	0.000897	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—kidney cancer	0.000673	0.000894	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—kidney cancer	0.000652	0.000867	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—kidney cancer	0.000647	0.00086	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—kidney cancer	0.000624	0.000829	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—kidney cancer	0.000543	0.000722	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—kidney cancer	0.000535	0.000711	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—kidney cancer	0.000518	0.000688	CcSEcCtD
Apomorphine—Dizziness—Doxorubicin—kidney cancer	0.0005	0.000665	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—kidney cancer	0.000481	0.000639	CcSEcCtD
Apomorphine—Headache—Doxorubicin—kidney cancer	0.000474	0.00063	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—kidney cancer	0.000449	0.000597	CcSEcCtD
Apomorphine—HTR1A—Signaling by GPCR—KRAS—kidney cancer	1.32e-05	0.000159	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—KRAS—kidney cancer	1.32e-05	0.000158	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PTEN—kidney cancer	1.31e-05	0.000158	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KDR—kidney cancer	1.31e-05	0.000157	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCND1—kidney cancer	1.3e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—JUN—kidney cancer	1.3e-05	0.000156	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—PIK3CA—kidney cancer	1.3e-05	0.000155	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	1.29e-05	0.000155	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	1.29e-05	0.000154	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CDKN1B—kidney cancer	1.29e-05	0.000154	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—POMC—kidney cancer	1.28e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—KRAS—kidney cancer	1.28e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.27e-05	0.000153	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	1.27e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—BRAF—kidney cancer	1.27e-05	0.000152	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CDKN1B—kidney cancer	1.27e-05	0.000152	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	1.27e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—POMC—kidney cancer	1.26e-05	0.000152	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL2—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—PIK3CA—kidney cancer	1.26e-05	0.000151	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PTEN—kidney cancer	1.25e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—RAF1—kidney cancer	1.25e-05	0.00015	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—BRAF—kidney cancer	1.25e-05	0.00015	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—RELA—kidney cancer	1.24e-05	0.000149	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL2—kidney cancer	1.24e-05	0.000149	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL2—kidney cancer	1.24e-05	0.000149	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	1.24e-05	0.000148	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—kidney cancer	1.23e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	1.23e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCND1—kidney cancer	1.23e-05	0.000147	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—JUN—kidney cancer	1.22e-05	0.000147	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MTOR—kidney cancer	1.22e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—kidney cancer	1.22e-05	0.000146	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	1.22e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CTNNB1—kidney cancer	1.21e-05	0.000146	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCND1—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCND1—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KIT—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APC—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—JUN—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—JUN—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RAF1—kidney cancer	1.21e-05	0.000145	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RELA—kidney cancer	1.2e-05	0.000144	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RAF1—kidney cancer	1.2e-05	0.000144	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CTNNB1—kidney cancer	1.2e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	1.2e-05	0.000144	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RELA—kidney cancer	1.19e-05	0.000143	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ERBB2—kidney cancer	1.19e-05	0.000143	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—kidney cancer	1.19e-05	0.000142	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ERBB2—kidney cancer	1.19e-05	0.000142	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PTEN—kidney cancer	1.18e-05	0.000142	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MTOR—kidney cancer	1.18e-05	0.000141	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTEN—kidney cancer	1.18e-05	0.000141	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	1.18e-05	0.000141	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	1.18e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MTOR—kidney cancer	1.17e-05	0.000141	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PTEN—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PTEN—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RAF1—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MAPK3—kidney cancer	1.17e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RELA—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—KRAS—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	1.16e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	1.15e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—kidney cancer	1.15e-05	0.000138	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RAF1—kidney cancer	1.15e-05	0.000138	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	1.14e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RELA—kidney cancer	1.14e-05	0.000137	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	1.14e-05	0.000137	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MAPK3—kidney cancer	1.14e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MTOR—kidney cancer	1.14e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	1.14e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	1.14e-05	0.000136	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—kidney cancer	1.13e-05	0.000136	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—kidney cancer	1.13e-05	0.000136	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK3—kidney cancer	1.12e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	1.12e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL2—kidney cancer	1.12e-05	0.000134	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—kidney cancer	1.11e-05	0.000133	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MAPK1—kidney cancer	1.11e-05	0.000133	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	1.11e-05	0.000133	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	1.1e-05	0.000132	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	1.1e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—kidney cancer	1.1e-05	0.000132	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—kidney cancer	1.09e-05	0.000131	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCND1—kidney cancer	1.09e-05	0.000131	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—JUN—kidney cancer	1.09e-05	0.000131	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MAPK1—kidney cancer	1.09e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	1.08e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2—kidney cancer	1.08e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2—kidney cancer	1.08e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK3—kidney cancer	1.07e-05	0.000129	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	1.07e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—kidney cancer	1.07e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK1—kidney cancer	1.07e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	1.07e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RAF1—kidney cancer	1.06e-05	0.000127	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—kidney cancer	1.05e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	1.05e-05	0.000127	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RELA—kidney cancer	1.05e-05	0.000127	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—kidney cancer	1.05e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PTEN—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—JUN—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB2—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—KRAS—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—JUN—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2—kidney cancer	1.05e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	1.04e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—kidney cancer	1.04e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RAF1—kidney cancer	1.04e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	1.04e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	1.04e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RELA—kidney cancer	1.04e-05	0.000124	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MTOR—kidney cancer	1.03e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	1.03e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2—kidney cancer	1.03e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—KRAS—kidney cancer	1.03e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—JUN—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PTEN—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MTOR—kidney cancer	1.02e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PTEN—kidney cancer	1.01e-05	0.000121	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK3—kidney cancer	1.01e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	1.01e-05	0.000121	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—KRAS—kidney cancer	1.01e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	1e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—JUN—kidney cancer	1e-05	0.00012	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK3—kidney cancer	9.98e-06	0.00012	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	9.98e-06	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	9.94e-06	0.000119	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PTEN—kidney cancer	9.85e-06	0.000118	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—kidney cancer	9.84e-06	0.000118	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—kidney cancer	9.7e-06	0.000116	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	9.7e-06	0.000116	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—kidney cancer	9.7e-06	0.000116	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	9.69e-06	0.000116	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—KRAS—kidney cancer	9.64e-06	0.000116	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	9.63e-06	0.000115	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK1—kidney cancer	9.62e-06	0.000115	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTEN—kidney cancer	9.57e-06	0.000115	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	9.55e-06	0.000115	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	9.55e-06	0.000115	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	9.52e-06	0.000114	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2—kidney cancer	9.5e-06	0.000114	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK1—kidney cancer	9.49e-06	0.000114	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	9.49e-06	0.000114	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	9.48e-06	0.000114	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RELA—kidney cancer	9.44e-06	0.000113	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	9.42e-06	0.000113	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	9.38e-06	0.000113	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2—kidney cancer	9.34e-06	0.000112	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—kidney cancer	9.31e-06	0.000112	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	9.27e-06	0.000111	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—kidney cancer	9.26e-06	0.000111	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	9.26e-06	0.000111	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—JUN—kidney cancer	9.24e-06	0.000111	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	9.19e-06	0.00011	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	9.17e-06	0.00011	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	9.14e-06	0.00011	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—kidney cancer	9.12e-06	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—kidney cancer	9.11e-06	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—JUN—kidney cancer	9.09e-06	0.000109	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—KRAS—kidney cancer	9.09e-06	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	9.02e-06	0.000108	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	9.01e-06	0.000108	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—kidney cancer	8.97e-06	0.000108	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—KRAS—kidney cancer	8.97e-06	0.000108	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—KRAS—kidney cancer	8.97e-06	0.000108	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PTEN—kidney cancer	8.94e-06	0.000107	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	8.89e-06	0.000107	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	8.85e-06	0.000106	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PTEN—kidney cancer	8.79e-06	0.000105	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—kidney cancer	8.76e-06	0.000105	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	8.75e-06	0.000105	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	8.7e-06	0.000104	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	8.69e-06	0.000104	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	8.65e-06	0.000104	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	8.57e-06	0.000103	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—kidney cancer	8.56e-06	0.000103	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2—kidney cancer	8.5e-06	0.000102	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—kidney cancer	8.46e-06	0.000101	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	8.41e-06	0.000101	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—kidney cancer	8.41e-06	0.000101	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	8.35e-06	0.0001	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—kidney cancer	8.31e-06	9.97e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	8.29e-06	9.94e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	8.28e-06	9.94e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	8.27e-06	9.93e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—JUN—kidney cancer	8.27e-06	9.92e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	8.24e-06	9.88e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	8.24e-06	9.88e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	8.23e-06	9.88e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	8.21e-06	9.85e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—kidney cancer	8.18e-06	9.82e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KRAS—kidney cancer	8.1e-06	9.71e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—kidney cancer	8.08e-06	9.69e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—kidney cancer	8.07e-06	9.68e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—kidney cancer	8.05e-06	9.66e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	8.01e-06	9.61e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	8e-06	9.6e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—kidney cancer	7.97e-06	9.56e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—kidney cancer	7.97e-06	9.56e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	7.94e-06	9.53e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	7.88e-06	9.45e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KRAS—kidney cancer	7.81e-06	9.38e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KRAS—kidney cancer	7.77e-06	9.33e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK3—kidney cancer	7.63e-06	9.16e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KRAS—kidney cancer	7.56e-06	9.07e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	7.51e-06	9.01e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	7.44e-06	8.93e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	7.44e-06	8.92e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—kidney cancer	7.43e-06	8.91e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—kidney cancer	7.31e-06	8.77e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK1—kidney cancer	7.26e-06	8.72e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	7.22e-06	8.67e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—kidney cancer	7.19e-06	8.63e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	7.18e-06	8.61e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	7.15e-06	8.58e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	7.14e-06	8.57e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	6.95e-06	8.34e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—kidney cancer	6.95e-06	8.33e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—kidney cancer	6.91e-06	8.29e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KRAS—kidney cancer	6.86e-06	8.23e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	6.84e-06	8.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	6.83e-06	8.2e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KRAS—kidney cancer	6.75e-06	8.1e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—kidney cancer	6.75e-06	8.1e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—kidney cancer	6.72e-06	8.06e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—kidney cancer	6.65e-06	7.98e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—kidney cancer	6.61e-06	7.94e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	6.5e-06	7.8e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	6.3e-06	7.56e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	6.2e-06	7.44e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	6.14e-06	7.37e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—kidney cancer	6.1e-06	7.32e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—kidney cancer	6e-06	7.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	5.64e-06	6.77e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—kidney cancer	5.46e-06	6.55e-05	CbGpPWpGaD
